1. 2015 Safe Kids Medicine Safety Program Launches

    The Safe Kids Medicine Safety Program, sponsored by McNeil Consumer Healthcare, has launched for its fourth year. This year's program is anchored by a research study that seeks to bring new insights into better understanding how children are getting into medicine and why medication errors occur.

    Read More

  2. Register Now for HIMSS15 and Get Member Rate!

    We invite you to join us at HIMSS15 April 12-16, 2015 in Chicago, Illinois! NCPDP is an Endorser and one of the expert resources at HIMSS15, so you’re eligible to receive the member discount to attend the conference. HIMSS15 will feature amazing education, innovative knowledge centers and features in the exhibit hall, and hundreds of networking opportunities.

    Read More

  3. Sandoz's Zarxio Approved by FDA as First Biosimilar

    On Friday March 6, 2015, the Food and Drug Administration approved the drug Zarxio, a cancer drug produced by Novartis' Sandoz unit as a lower-cost biosimilar alternative to Amgen's Neupogen. Read Press Release.

    Read More

  4. ePA National Adoption Scorecard Released

    CoverMyMeds, NCPDP's Inaugural Elite Partner, working with a group of industry stakeholders, released the Electronic Prior Authorization (ePA) National Adoption Scorecard. The ePA National Adoption Scorecard highlights the current state of the ePA industry, including ePA adoption rates and implementation statuses of the industry's largest participants. View the press release for more information.

    Read More

  5. ICD-10 Readiness Survey

    The Workgroup for Electronic Data Interchange (WEDI) is conducting an ICD-10 readiness survey to determine how well the healthcare industry is progressing toward the October 1, 2015 implementation deadline.

    Read More

For problems with the site please contact us at webmaster@ncpdp.org